Eledon Pharmaceuticals, Inc. Capital Expenditures Incurred but Not yet Paid
Eledon Pharmaceuticals, Inc. (ELDN) reported Capital Expenditures Incurred but Not yet Paid of $98.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2016-11-03
- Eledon Pharmaceuticals, Inc. capital expenditures incurred but not yet paid for the quarter ending 2015-09-30 was -$37.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|---|
| 2015-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $98.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $135.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |